Kenji Zennami

720 citations
60 papers · 497 indexed · h-index 12
Topics
Bladder and Urothelial Cancer Treatments (23 papers)Prostate Cancer Treatment and Research (14 papers)Prostate Cancer Diagnosis and Treatment (11 papers)

In The Last Decade

Kenji Zennami

56 papers receiving 495 citations

Peers

Kenji Zennami
Comparison fields: 5 of 76
  • Pulmonary and Respiratory Medicine 201
  • Surgery 150
  • Molecular Biology 148
  • Oncology 125
  • Cancer Research 87
Replace Verena Ellerkamp with:
Verena Ellerkamp Germany
Sheng Cheng China
Jin‐Bei Huang China
Martina Bonacini Italy
Haimin Zhang China
Kazuaki Machioka Japan
Cuijian Zhang China
Satoshi Tsukikawa Japan
Jacques F. Bogdanowicz Netherlands
Takuto Shimizu Japan
Kenji Zennami relative to Verena Ellerkamp Germany Verena Ellerkamp's profile →
Citations per field
00.5×
Verena Ellerkamp · 1×
Citations per year

Countries citing papers authored by Kenji Zennami

Since Specialization
Citations

This map shows the geographic impact of Kenji Zennami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Zennami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Zennami more than expected).

Fields of papers citing papers by Kenji Zennami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Zennami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Zennami. The network helps show where Kenji Zennami may publish in the future.

Co-authorship network of co-authors of Kenji Zennami

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Zennami. A scholar is included among the top collaborators of Kenji Zennami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Zennami. Kenji Zennami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 1
4 7
5 10
6 1
7 3
8 1
9 11
10 20
11 10
12 8
13 30
14 17
15 17
16 16
17 3
18 8
19 4
20 10

About Kenji Zennami

Kenji Zennami is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 60 papers that have together received 497 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (23 papers), Prostate Cancer Treatment and Research (14 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). The work is most often cited by research in Urology (55 citations), Pulmonary and Respiratory Medicine (201 citations) and Cancer Research (87 citations). Kenji Zennami has collaborated with scholars based in Japan, United States and Thailand. Frequent co-authors include Makoto Sumitomo, Kogenta Nakamura, Yoshiaki Yamada, Ryoichi Shiroki, Kiyoshi Takahara, Manabu Ichino, Yoshiharu Kato, Hitomi Sasaki, Tomohiro Taki and Shigeyuki Aoki. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026